The summary below is from the full report titled “Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness.” It is in the 20 March 2001 issue of Annals of Internal Medicine (volume 134, pages 440-450). The authors are MC Weinstein, SJ Goldie, E Losina, CJ Cohen, JD Baxter, H Zhang, AD Kimmel, and KA Freedberg.
The Cost-Effectiveness of Testing HIV for Genetic Signs of Drug Resistance as a Guide to the Choice of Therapy. Ann Intern Med. 2001;134:I–89. doi: https://doi.org/10.7326/0003-4819-134-6-200103200-00004
Download citation file:
Published: Ann Intern Med. 2001;134(6):I-89.
Healthcare Delivery and Policy, HIV, Infectious Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use